Auditory function after continuous infusion of gentamicin to high-risk newborns.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Auditory function after continuous infusion of gentamicin to high-risk newborns. / Colding, H; Andersen, E A; Prytz, S; Wulffsberg, H; Andersen, G E.
I: Acta Paediatrica Scandinavica, Bind 78, Nr. 6, 1989, s. 840-3.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Auditory function after continuous infusion of gentamicin to high-risk newborns.
AU - Colding, H
AU - Andersen, E A
AU - Prytz, S
AU - Wulffsberg, H
AU - Andersen, G E
N1 - Keywords: Audiometry; Auditory Threshold; Follow-Up Studies; Gentamicins; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Intensive Care Units, Neonatal
PY - 1989
Y1 - 1989
N2 - Audiometry was performed at four years of age in 69 of 105 surviving children who had received continuous intravenous infusion of gentamicin during neonatal intensive care. A hearing loss of 20 dB was found in 2 of them (3%), corresponding to that shown in other studies of survivors following neonatal intensive care. Free field audiometry performed in another 7 children and questionnaires returned from 13 of the remaining 29 gave no suspicion of hearing loss. Thus there is no indication that continuous 24 hours intravenous infusion of gentamicin causes more hearing impairment than intermittent intravenous or intramuscular administration.
AB - Audiometry was performed at four years of age in 69 of 105 surviving children who had received continuous intravenous infusion of gentamicin during neonatal intensive care. A hearing loss of 20 dB was found in 2 of them (3%), corresponding to that shown in other studies of survivors following neonatal intensive care. Free field audiometry performed in another 7 children and questionnaires returned from 13 of the remaining 29 gave no suspicion of hearing loss. Thus there is no indication that continuous 24 hours intravenous infusion of gentamicin causes more hearing impairment than intermittent intravenous or intramuscular administration.
M3 - Journal article
C2 - 2603707
VL - 78
SP - 840
EP - 843
JO - Acta Paediatrica Scandinavica
JF - Acta Paediatrica Scandinavica
SN - 0001-656X
IS - 6
ER -
ID: 8670129